UBS Group’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.96M | Sell |
|
|||||
|
2025
Q2 | $3.07M | Buy |
|
|||||
|
2025
Q1 | $3.57M | Buy |
|
|||||
|
2024
Q4 | $8.27M | Buy |
|
|||||
|
2024
Q3 | $2.58M | Buy |
|
|||||
|
2024
Q2 | $1.64M | Sell |
|
|||||
|
2024
Q1 | $5.44M | Buy |
|
|||||
|
2023
Q4 | $6.2M | Buy |
|
|||||
|
2023
Q3 | $4.7M | Buy |
|
|||||
|
2023
Q2 | $54.8K | Sell |
|
|||||
|
2023
Q1 | $387K | Buy |
|
|||||
|
2022
Q4 | $104K | Sell |
|
|||||
|
2022
Q3 | $138K | Buy |
|
|||||
|
2022
Q2 | $28K | Buy |
|
|||||
|
2022
Q1 | $21K | Sell |
|
|||||
|
2021
Q4 | $140K | Buy |
|
|||||
|
2021
Q3 | $32K | Buy |
|
|||||
|
2021
Q2 | $41K | Buy |
|
|||||
|
2021
Q1 | $35K | Sell |
|
|||||
|
2020
Q4 | $32K | Sell |
|
|||||
|
2020
Q3 | $57K | Buy |
|